Dr Felipe Antonio Velez Gonzalez, MD | |
600 St. Km 5.8, Angeles, PR 00611-0145 | |
(787) 754-0101 | |
Not Available |
Full Name | Dr Felipe Antonio Velez Gonzalez |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 17 Years |
Location | 600 St. Km 5.8, Angeles, Puerto Rico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790012524 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Felipe Antonio Velez Gonzalez, MD Po Box 145, Angeles, PR 00611-0145 Ph: (787) 754-0101 | Dr Felipe Antonio Velez Gonzalez, MD 600 St. Km 5.8, Angeles, PR 00611-0145 Ph: (787) 754-0101 |
News Archive
Medicare card sponsors of drug discount cards who pay pharmacists to attract customers to their cards could violate federal fraud and abuse laws, health inspectors warned Friday.
Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children are vaccinated, is continuing as planned, and now with more money behind it. "I am still hopeful that the GAD vaccine will work", says Helena Elding Larsson.
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today announced OICR is investing $4.6 million over two years in PanCuRx, an initiative that seeks solutions to the high fatality rate of pancreatic cancer.
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and online education resources, today announced the availability of Well-Connected, its online health and wellness subscription-based product for the public library and information dissemination markets, featuring enhanced functionalities and user-friendly interfaces for library patrons.
Medco Health Solutions, Inc. today reported second-quarter 2010 GAAP diluted EPS of $0.77, up 20.3 percent compared to $0.64 for the second quarter of 2009. Adjusting for the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, second-quarter 2010 diluted earnings per share increased 20.3 percent to $0.83, from $0.69 in the second quarter of 2009.
› Verified 9 days ago